Skip to content
akaturk Academic measurement
Search

Article detail · 2017 · article

Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group

ISSN2149-3235
YÖKSİS OpenAlex Open access · bronze TR Index Top 10%
Year2017
Citations65OpenAlex
Citations56Semantic Scholar · 2 influential
Percentile%95.3
FWCI4.191.00 = world average
Scopus (SJR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueTürk Üroloji Dergisi/Turkish Journal of Urology
  • Catalog match (ISSN)Turkish Journal of Urology
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

OBJECTIVE: Previous study conducted by the Turkish Society of Andrology in 1999 reported the prevalence of erectile dysfunction (ED) as 69.2% in men of ≥40 years of age, using a single-item non-validated question. This rate seemed to be higher compared to the studies reported worldwide. So, there was a need to carry out another epidemiological study by using validated questionnaires. Our aim was to investigate ED prevalence, severity, and its correlates in men aged ≥40 years using validated tools. MATERIAL AND METHODS: This cross-sectional, observational, population-based field survey was carried out in randomly selected males of ≥40 years from 19 provinces of Turkey. All participant completed a survey included with socio-demographic and socio-economic characteristics, medical and sexual history, associated physical and medical comorbidities. Erectile function was assessed by the International Index of Erectile Function (IIEF) questionnaire based on a total score of 30. The prevalence of ED, its severity and correlates in men aged ≥40 years were determined for main outcome measures. Data sets were statistically compared and p<0.05 was considered as significant. RESULTS: Median age of 2.760 males was 54.2 years. The median prevalence of ED was calculated as 33% among all males of ≥40 years of age. When subjects were stratified by age; median ED prevalence rates were 17% for 40-49 years, 35.5% for 50-59 years, 68.8% for 60-69 years, and 82.9% for ≥70 years. Among all ED men, 76.9% reported mild, 16.3% moderate, and 5.7% severe ED. At logistic regression analyses; age, diabetes, hypertension, atherosclerosis, dyslipidemia, lower urinary tract symptoms, educational status and monthly income were found to be independent risk factors for having ED. CONCLUSION: This population-based survey in Turkish men of ≥40 years of age reported the prevalence of ED as 33%. Besides, this study reported age as the main predictor for presence and severity of ED.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

65citationsOpenAlex · cited_by_count (cache / database)

36 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2020 Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort studyCitations 131 · OpenAlex
  2. 2020 Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort studyCitations 131 · OpenAlex
  3. 2019 The relationship between erectile dysfunction and the Atherogenic Index of PlasmaCitations 18 · OpenAlex
  4. 2020 Effect of microsurgical varicocele repair on sexual functions and testosterone in hypogonadal infertile men with varicoceleCitations 10 · OpenAlex
  5. 2020 The effect of partial and total laryngectomy on couples’xx sexual functions in men with larynx cancerCitations 9 · OpenAlex
  6. 2020 The effect of partial and total laryngectomy on couples’ sexual functions in men with larynx cancerCitations 9 · OpenAlex
  7. 2020 Changing Aspects of Male Sexual Functions Accompanying Treatment of Benign Prostatic Hyperplasia with Silodosin 8 mg Per DayCitations 8 · OpenAlex
  8. 2020 Changing Aspects of Male Sexual Functions Accompanying Treatment of Benign Prostatic Hyperplasia With Silodosin 8 mg Per DayCitations 8 · OpenAlex
  9. 2020 Can Subfoveal Choroidal Thickness Replace Subjective Tests In Patients Using Tadalafil To Treat Erectile Dysfunction?Citations 8 · OpenAlex
  10. 2020 Can subfoveal choroidal thickness replace subjective tests in patients using tadalafil to treat erectile dysfunction?Citations 8 · OpenAlex

Authors

8
  1. SELAHİTTİN ÇAYAN MERSİN ÜNİVERSİTESİ 1
  2. MUAMMER KENDİRCİ 2
  3. MUHİDDİN ÖNDER YAMAN ANKARA ÜNİVERSİTESİ 3
  4. RAMAZAN AŞCI 4
  5. İRFAN ORHAN FIRAT ÜNİVERSİTESİ 5
  6. MUSTAFA FARUK USTA 6
  7. OĞUZ EKMEKÇİOĞLU 7
  8. ATEŞ KADIOĞLU 8